Roche Diabetes Care Inc
UnclaimedIn-Vitro Diagnostic Substance ManufacturingIndianapolis, IN
Founded
2015
Primary NAICS
325413
CAGE code
7DZ31
Federal awards
$3.4M
Classification
This U.S. industry comprises establishments primarily engaged in manufacturing in-vitro (i.e., not taken internally) diagnostic substances, such as chemical, biological, or radioactive substances. The substances are used for diagnostic tests that are performed in test tubes, petri dishes, machines, and other diagnostic test-type devices.
- Manufacturing32
- Chemical Manufacturing325
- Pharmaceutical and Medicine Manufacturing32541
- In-Vitro Diagnostic Substance Manufacturing325413
Federal awards
| Year | Agency | Obligated | Actions |
|---|---|---|---|
| 2026 | Department of Health and Human Services | $343,132 | 4 |
| 2026 | Department of Veterans Affairs | $0 | 5 |
| 2025 | Department of Health and Human Services | $718,148 | 6 |
| 2025 | Department of Veterans Affairs | $0 | 2 |
| 2024 | Department of Health and Human Services | $178,704 | 7 |
| 2024 | Department of Justice | $85,389 | 3 |
| 2024 | Department of Veterans Affairs | $0 | 3 |
| 2023 | Department of Health and Human Services | $1,122,995 | 9 |
| 2023 | Department of Justice | $484,669 | 22 |
| 2023 | Department of Veterans Affairs | $0 | 2 |
| 2022 | Department of Justice | $384,405 | 14 |
| 2022 | Department of Health and Human Services | $69,649 | 7 |
| 2022 | Department of Veterans Affairs | $0 | 5 |